Send to

Choose Destination
See comment in PubMed Commons below
Mol Cell Probes. 2011 Apr-Jun;25(2-3):134-6. doi: 10.1016/j.mcp.2011.01.005. Epub 2011 Jan 31.

No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.

Author information

  • 1Stanley Division of Developmental Virology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21287, United States.


New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.

Copyright © 2011 Elsevier Ltd. All rights reserved.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk